343 related articles for article (PubMed ID: 23291946)
1. mRNA: From a chemical blueprint for protein production to an off-the-shelf therapeutic.
Van Lint S; Heirman C; Thielemans K; Breckpot K
Hum Vaccin Immunother; 2013 Feb; 9(2):265-74. PubMed ID: 23291946
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo pulsed dendritic cell vaccination against cancer.
Gu YZ; Zhao X; Song XR
Acta Pharmacol Sin; 2020 Jul; 41(7):959-969. PubMed ID: 32366940
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy.
Anguille S; Lion E; Van den Bergh J; Van Acker HH; Willemen Y; Smits EL; Van Tendeloo VF; Berneman ZN
Hum Vaccin Immunother; 2013 Sep; 9(9):1956-61. PubMed ID: 23778748
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of cancer with dendritic cells loaded with tumor antigens and activated through mRNA electroporation.
Van Nuffel AM; Corthals J; Neyns B; Heirman C; Thielemans K; Bonehill A
Methods Mol Biol; 2010; 629():405-52. PubMed ID: 20387165
[TBL] [Abstract][Full Text] [Related]
5. The ReNAissanCe of mRNA-based cancer therapy.
Van Lint S; Renmans D; Broos K; Dewitte H; Lentacker I; Heirman C; Breckpot K; Thielemans K
Expert Rev Vaccines; 2015 Feb; 14(2):235-51. PubMed ID: 25263094
[TBL] [Abstract][Full Text] [Related]
6. mRNA-based dendritic cell vaccines.
Benteyn D; Heirman C; Bonehill A; Thielemans K; Breckpot K
Expert Rev Vaccines; 2015 Feb; 14(2):161-76. PubMed ID: 25196947
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell-based cancer immunotherapies.
Fujii S; Takayama T; Asakura M; Aki K; Fujimoto K; Shimizu K
Arch Immunol Ther Exp (Warsz); 2009; 57(3):189-98. PubMed ID: 19479202
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of mRNA trimannosylated lipopolyplexes as therapeutic cancer vaccines targeting dendritic cells.
Le Moignic A; Malard V; Benvegnu T; Lemiègre L; Berchel M; Jaffrès PA; Baillou C; Delost M; Macedo R; Rochefort J; Lescaille G; Pichon C; Lemoine FM; Midoux P; Mateo V
J Control Release; 2018 May; 278():110-121. PubMed ID: 29630987
[TBL] [Abstract][Full Text] [Related]
10. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
11. mRNA Cancer Vaccines-Messages that Prevail.
Grunwitz C; Kranz LM
Curr Top Microbiol Immunol; 2017; 405():145-164. PubMed ID: 28401358
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cell-based vaccines and therapies for cancer.
Tatsumi T; Storkus WJ
Expert Opin Biol Ther; 2002 Dec; 2(8):919-28. PubMed ID: 12517270
[TBL] [Abstract][Full Text] [Related]
13. Personalized dendritic cell-based tumor immunotherapy.
Janikashvili N; Larmonier N; Katsanis E
Immunotherapy; 2010 Jan; 2(1):57-68. PubMed ID: 20161666
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of antigen loading strategies of dendritic cells for tumor immunotherapy.
Shimizu K; Kuriyama H; Kjaergaard J; Lee W; Tanaka H; Shu S
J Immunother; 2004; 27(4):265-72. PubMed ID: 15235387
[TBL] [Abstract][Full Text] [Related]
15. mRNA therapeutics in cancer immunotherapy.
Beck JD; Reidenbach D; Salomon N; Sahin U; Türeci Ö; Vormehr M; Kranz LM
Mol Cancer; 2021 Apr; 20(1):69. PubMed ID: 33858437
[TBL] [Abstract][Full Text] [Related]
16. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.
Bonehill A; Van Nuffel AM; Corthals J; Tuyaerts S; Heirman C; François V; Colau D; van der Bruggen P; Neyns B; Thielemans K
Clin Cancer Res; 2009 May; 15(10):3366-75. PubMed ID: 19417017
[TBL] [Abstract][Full Text] [Related]
17. Advances and challenges: dendritic cell vaccination strategies for glioblastoma.
Schaller TH; Sampson JH
Expert Rev Vaccines; 2017 Jan; 16(1):27-36. PubMed ID: 27500911
[TBL] [Abstract][Full Text] [Related]
18. Genetically modified dendritic cells in cancer therapy: implications for transfusion medicine.
Foley R; Tozer R; Wan Y
Transfus Med Rev; 2001 Oct; 15(4):292-304. PubMed ID: 11668436
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic mRNA-based electrotransfection of autologous dendritic cells and specific antitumor effects against osteosarcoma in rats.
Yu Z; Qian J; Wu J; Gao J; Zhang M
Med Oncol; 2012 Dec; 29(5):3440-8. PubMed ID: 22843292
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell fusion vaccines for cancer immunotherapy.
Rosenblatt J; Kufe D; Avigan D
Expert Opin Biol Ther; 2005 May; 5(5):703-15. PubMed ID: 15934845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
